Koers Agentix Corp. Other OTC
Aandelen
AGTX
US00848A1034
Farmaceutische producten
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 3,91 mln. 3,66 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,81 mln. | Nettowinst (verlies) 2023 | -1 mln. -935K | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 145 135,61 | Nettoschuld 2023 | 37,63K 35,19K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-2,35
x | K/w-verhouding 2023 |
-2,86
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 76,47% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Salman Hoda
CHM | Chairman | 44 | 14-12-20 |
Martin Schroeder
CTO | Chief Tech/Sci/R&D Officer | - | - |
David Fiene
AUD | Comptroller/Controller/Auditor | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rehan Huda
BRD | Director/Board Member | 54 | 02-07-20 |
Salman Hoda
CHM | Chairman | 44 | 14-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,66% | 86,13 mld. | |
+1,32% | 39,82 mld. | |
-19,27% | 30,42 mld. | |
+57,86% | 25,23 mld. | |
-16,09% | 15,36 mld. | |
-9,14% | 11,95 mld. | |
-17,69% | 11,6 mld. | |
-43,00% | 11,51 mld. | |
+5,24% | 8,71 mld. |